Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease

被引:285
作者
Eguchi, Yuichiro
Eguchi, Takahisa
Mizuta, Toshihiko
Ide, Yasushi
Yasutake, Tsutomu
Iwakiri, Ryuichi
Hisatomi, Akitaka
Ozaki, Iwata
Yamamoto, Kyousuke
Kitajima, Yoichiro
Kawaguchi, Yasunori
Kuroki, Shigetaka
Ono, Naofumi
机构
[1] Saga Med Sch, Dept Internal Med, Saga 8498501, Japan
[2] Eguchi Hosp, Saga, Japan
关键词
nonalcoholic fatty liver disease; insulin resistance; visceral fat; metabolic syndrome; ultrasonography;
D O I
10.1007/s00535-006-1790-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Nonalcoholic fatty liver diseases are often associated with obesity, insulin resistance, and excessive visceral fat accumulation. The aims of this study were (1) to evaluate the relationship between the severity of fatty liver and visceral fat accumulation in nonalcoholic fatty liver diseases, and (2) to investigate the relationships of fatty liver with biochemical data and insulin resistance. Methods. One hundred twenty-nine subjects (63 women) with fatty liver diagnosed by ultrasonography were enrolled. Subjects positive for hepatitis B virus, hepatitis C virus, or autoimmune antibodies and those whose alcohol intake was over 20g/day were excluded. The visceral fat area at the umbilical level and the liver-spleen ratio were evaluated by computed tomography. Results. The severity of fatty liver evaluated by ultrasonography showed a significant positive relationship with the visceral fat area and waist circumstance (fatty liver severity: mild, 92.0 +/- 30.9cm(2); moderate, 122.1 +/- 32.6cm(2); severe, 161.0 +/- 48.4cm(2); P < 0.0001). The visceral fat area and liver-spleen ratio were negatively correlated (r = -0.605, P < 0.0001). The severity of fatty liver showed strong positive relationships with serum aspartate aminotransferase, alanine aminotransferase, fasting plasma glucose, fasting plasma insulin, and insulin resistance. The severity of fatty liver was positively related to the visceral fat area in 49 nonobese subjects (body mass index < 25). Conclusions. The severity of fatty liver was positively correlated with visceral fat accumulation and insulin resistance in both obese and nonobese subjects, suggesting that hepatic fat infiltration in nonalcoholic fatty liver disease may be influenced by visceral fat accumulation regardless of body mass index.
引用
收藏
页码:462 / 469
页数:8
相关论文
共 31 条
[1]
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]
2-S
[3]
[Anonymous], AS PAC PERSP RED OB
[4]
Risk of cancer from diagnostic X-rays:: estimates for the UK and 14 other countries [J].
Berrington de González, A ;
Darby, S .
LANCET, 2004, 363 (9406) :345-351
[5]
The role of TNF-α in insulin resistance [J].
Borst, SE .
ENDOCRINE, 2004, 23 (2-3) :177-182
[6]
Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome [J].
Carr, DB ;
Utzschneider, KM ;
Hull, RL ;
Kodama, K ;
Retzlaff, BM ;
Brunzell, JD ;
Shofer, JB ;
Fish, BE ;
Knopp, RH ;
Kahn, SE .
DIABETES, 2004, 53 (08) :2087-2094
[7]
IS HEPATIC ULTRASONOGRAPHY A VALID ALTERNATIVE TOOL TO LIVER-BIOPSY - REPORT ON 507 CASES STUDIED WITH BOTH TECHNIQUES [J].
CELLE, G ;
SAVARINO, V ;
PICCIOTTO, A ;
MAGNOLIA, MR ;
SCALABRINI, P ;
DODERO, M .
DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (04) :467-471
[8]
Nonalcoholic Fatty Liver Disease: A Review of Current Understanding and Future Impact [J].
Charlton, Michael .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (12) :1048-1058
[9]
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J].
Chitturi, S ;
Abeygunasekera, S ;
Farrell, GC ;
Holmes-Walker, J ;
Hui, JM ;
Fung, C ;
Karim, R ;
Lin, R ;
Samarasinghe, D ;
Liddle, C ;
Weltman, M ;
George, J .
HEPATOLOGY, 2002, 35 (02) :373-379
[10]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497